Drug counterfeiting is an enormous problem in developing countries with up to 40 percent of drugs suspected as fake.
Counterfeit drugs are not a new phenomenon; what is new is the scale and sophistication of the counterfeit drug operation, argues Nigel Layton, founder and CEO of leading corporate security and professional intelligence consultancy Quest.
Bruce Hudson, Programme Director for Technology Research Services at META Group, says it?s not as simple as that ?¬ but does admit that ?we?re only now at the tip of the iceberg for what RFID is going to do.?